Elicio Therapeutics Inc.

NASDAQ:ELTX

7.81

-0.18 (-2.25%)

4:49:15 PM EDT: $7.70 -0.11 (-1.41%)

Elicio Therapeutics Inc. Stock, NASDAQ:ELTX

451 D Street, 5th floor, Boston, Massachusetts 02210

United States of America

Phone: +1.857.209.0050

Number of Employees: 12

http://www.elicio.com

Description

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Boston, MA.